With the share of Medicaid beneficiaries enrolled in managed care past the halfway mark, a new online tool from the Kaiser Family Foundation will help policymakers and researchers track its status in 39 states.
With half the nation’s 67.9 million Medicaid beneficiaries in managed care and that share growing, the Kaiser Family Foundation (KFF) yesterday unveiled an interactive, online tool that lets users evaluate data gathered from the 39 states that enroll clients in managed care.
The Medicaid Managed Care Market Tracker is part of KFF’s State Health Facts data center. A statement from the foundation says it will provide “the latest data on key dimensions of risk-based Medicaid managed care for the 39 states that contract with MCOs—these states are home to more than 90% of all Medicaid beneficiaries.”
Elements on the tracker will include:
KFF’s statement notes that 19 states that account for 45% of Medicaid enrollees publicly report their information, while data from the others will be gathered from multiple secondary sources.
The Kaiser tool comes at a time when states are continuing their march into managed care for Medicaid administration, with extensive use of third-party contractors, despite reports of difficult transitions around the country. Prior to its widely praised launch of its exchange to enroll clients under the Affordable Care Act, Kentucky struggled with a rapid transfer to Medicaid managed care. As is often the case, officials told The American Journal of Managed Care that their hand was forced by a budget crisis.
Since then, Kansas’ experiment with Medicaid managed care has resulted in complaints about slow payments and losses for insurers, while in Ohio, news reports tell of doctors balking at taking new Medicaid patients in managed care, due to problems such as getting diagnostic tests approved.
New Hampshire delayed moving some of its most vulnerable Medicaid clients into managed care indefinitely. And this week in California, advocates braced for the transition of rural, frail elderly Medicaid patients into managed care, after the 2011 transfer of non-rural patients went poorly.
Yet KFF’s earlier survey of Medicaid directors found that most states plan to expand managed care in the program to hold down costs. Thus, the KFF tool will help researchers and policymakers track how well MCOs are performing in individual locations and nationally.
Along with the tracker, KFF this week also released a report on the state of Medicaid managed care by Julia Paradise, associate director of the foundation’s Commission on Medicaid and the Uninsured. Her report contains many state-by-state on MCO spending, penetration by several well-known national insurers into the Medicaid managed care market, and the prospects for expansion in 2015.
For example, while Medicaid managed care exists in 39 states, market penetration varies. In 2013, 5 states—Arizona, New Mexico, Tennessee, Delaware and Hawaii—covered 60% of the beneficiaries; 9 states covered 35% to 59% of their beneficiaries with MCOs, and the remaining 25 states covered less than 35% of beneficiaries through managed care.
According to Paradise’s report, 5 firms have a large geographic presence nationally: UnitedHealth is in 20, WellPoint, 17; Centene, 15; Aetna 11; and Molina, 11.
Paradise will host a webinar on how to use the KFF online tool on December 11, according to the statement.
Around the Web
New Interactive Data Tool Tracks Medicaid Managed Care Market
Key Findings on Medicaid Managed Care: Highlights from the Medicaid Managed Care Market Tracker
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
High Rates of Misdiagnosis in Hair, Scalp Disorders Among Patients With Skin of Color
August 13th 2025Hair and scalp disorders in patients with skin of color are frequently misdiagnosed, often due to educational gaps and premature diagnosis, with scalp biopsy proving more reliable than trichoscopy for accurate diagnosis.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions
August 13th 2025More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older age, multiple comorbidities, and more than 2000 potential drug-to-drug interactions.
Read More